Author:
González-Fernández Mariángeles,Villamañán Elena,Jiménez-Nácher Inmaculada,Moreno Francisco,Plasencia Chamaida,Gaya Francisco,Herrero Alicia,Balsa Alejandro
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology,Toxicology,Pharmacy
Reference32 articles.
1. Zochling J, Smith EUR. Seronegative spondyloarthritis. Best Pract Res Clin Rheumatol. 2010;24:747–56.
2. Hukuda S, Minami M, Saito T, Mitsui H, Matsui N, Komatsubara Y, et al. Spondyloarthropathies in Japan: nationwide questionnaire survey performed by the Japan Ankylosing Spondylitis Society. J Rheumatol. 2001;28:554–9.
3. Muñoz-Fernández S, de Miguel E, Cobo-Ibáñez T, Carmona L, Steiner M, Descalzo MA, et al. Early spondyloarthritis: results from the pilot registry ESPIDEP. Clin Exp Rheumatol. 2010;28:498–503.
4. Quintana G, Coral-Alvarado P. Economic impact of rheumatic diseases. Chall Rheumatol [Internet]. 2011.
http://www.intechopen.com/books/challenges-in-rheumatology/economic-impact-of-rheumatic-diseases
. Citado 5 marzo 2018.
5. Ward MM, Deodhar A, Akl EA, Lui A, Ermann J, Gensler LS, et al. American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheumatol Hoboken NJ. 2016;68:282–98.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献